Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Pancreas Cancer
41%
Structure Activity Relationship
40%
Quinoxaline
34%
Dimer
33%
Chronic Lymphatic Leukemia
29%
Anticarcinogen
29%
Phosphotransferase
26%
Phosphotransferase Inhibitor
25%
Colorectal Cancer
25%
Butyrolactone
22%
Venetoclax
20%
Hyaluronic Acid
19%
Heme
19%
Isatin
19%
Proline
19%
Cyclin Dependent Kinase 9
19%
Mouse
18%
Tumor Necrosis Factor
17%
High-Throughput Screening
16%
Antiapoptotic
15%
Initiation Factor 2alpha
13%
Ibrutinib
13%
Protein Kinases
12%
Cyclin Dependent Kinase
12%
Neoplasm
12%
Cyclin Dependent Kinase Inhibitor
12%
Carbene
12%
I Kappa B Kinase Inhibitor
12%
Cyclin Dependent Kinase 5
11%
Binding Site
11%
Initiation Factor 2
11%
Disease
11%
Plasma Protein
10%
Phosphoprotein
10%
Ovary Cancer
10%
Colon Cancer
9%
Triazole
9%
B Cell Lymphoma
9%
Oxide
9%
Protein Binding
9%
Hexane
9%
Protein Tyrosine Kinase
9%
Navitoclax
9%
Ferulic Acid
9%
Cyclic GMP Dependent Protein Kinase
9%
Deubiquitinase
9%
Troglitazone
9%
Indocyanine Green
9%
Pharmacokinetics
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
61%
Small Molecule
33%
Protein-Protein Interaction
33%
BRCA1
31%
Receptor Tyrosine Kinase
29%
DNA Repair
29%
Kinase
26%
Phosphotransferase
26%
Structure Activity Relation
26%
Crystal Structure
23%
Phosphoprotein
23%
Protein Catabolism
20%
Proline
19%
Tyrosine Kinase
19%
Binding Protein
19%
Unfolded Protein Response
19%
Fluorescein
19%
Cyclin-Dependent Kinase 9
19%
Cyclin-Dependent Kinase
17%
Binding Site
17%
DNA Damage
17%
Conformation
14%
BACH1
14%
Tetrapeptide
14%
BRCT Domain
14%
High Throughput Screening
14%
Ubiquitination
13%
Cell Growth
12%
RAD52
12%
Cysteine
12%
Mouse
12%
Ubiquitin Ligase
12%
Replication Protein A
11%
Cyclic Adenosine Monophosphate
11%
Bcl-xL
11%
Endoplasmic Reticulum Stress
11%
Cytotoxicity
11%
Anticancer
11%
Binding Domain
11%
DNA Damage Response
10%
Homologous Recombination
10%
Endonuclease
9%
AP Endonuclease
9%
Eukaryotic Initiation Factor
9%
Apyrimidinic Site
9%
Rhodamine
9%
Deoxyribonuclease I
9%
Dephosphorylation
9%
T Cell
9%
CGMP-dependent Protein Kinase
9%
Keyphrases
Structure-activity Relationship Studies
43%
Isatin
32%
Urea Analogues
32%
Anticancer Agents
29%
Ovarian Cancer
22%
Quinoxaline
22%
Methylene
22%
γ-butyrolactone
22%
Pro-survival
21%
NF-B
20%
Dual Targeting
19%
G-quadruplex DNA
19%
Proteolysis Targeting chimera (PROTAC)
19%
Phosphorylation
19%
Spirocyclic
16%
Fluorescence Polarization Assay
16%
Colorectal Cancer Prevention
16%
Tumor Necrosis Factor-α
16%
Cancer Cells
14%
Antiproliferative Activity
12%
Nuclear factor-κB
12%
Nuclear Translocation
12%
Protein-protein Interaction Assay
12%
Inhibitor Screening
12%
CDK Inhibitors
11%
Amino Pyrazole
11%
B-cell Lymphoma 2 (Bcl-2)
10%
Myeloid Cell leukemia-1 (Mcl-1)
10%
Breast Cancer Cells
10%
Venetoclax
10%
Oncotarget
9%
Structural Characterization
9%
Quinoxaline Derivatives
9%
Hyperfractionated
9%
1,2,4-triazole
9%
Synthetic Study
9%
Peptide Truncation
9%
Aryl Urea
9%
Cluster of Differentiation 44 (CD44)
9%
Cyclin-dependent Kinase 6 (CDK6)
9%
Pancreatic Duct Cells
9%
Binding Interaction
9%
Lysine Analogs
9%
Eight-step
9%
Radio Frequency Power
9%
Rotating Frame
9%
Paclitaxel Chemosensitivity
9%
Pulse Design
9%
Tetrapeptide
9%
Induced Apoptosis
9%
